 John Repine
Concepts (733)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neutrophils | 120 | 2005 | 1207 | 4.510 |
Why?
| | Interleukin-1 | 32 | 2015 | 959 | 2.920 |
Why?
| | Xanthine Oxidase | 43 | 2003 | 78 | 2.910 |
Why?
| | Lung | 93 | 2013 | 3927 | 2.690 |
Why?
| | Oxygen | 54 | 2016 | 914 | 2.650 |
Why?
| | Hydrogen Peroxide | 49 | 2002 | 317 | 2.210 |
Why?
| | Rats | 102 | 2015 | 5479 | 1.520 |
Why?
| | Oxidative Stress | 12 | 2016 | 1265 | 1.360 |
Why?
| | Catalase | 41 | 1997 | 128 | 1.360 |
Why?
| | Antioxidants | 13 | 2012 | 558 | 1.230 |
Why?
| | Superoxides | 28 | 1999 | 201 | 1.180 |
Why?
| | Pulmonary Edema | 23 | 1997 | 106 | 1.090 |
Why?
| | Thiourea | 29 | 1995 | 39 | 1.090 |
Why?
| | Macrophages, Alveolar | 4 | 2016 | 389 | 1.060 |
Why?
| | Rats, Sprague-Dawley | 38 | 2015 | 2395 | 1.040 |
Why?
| | Endothelium, Vascular | 16 | 2002 | 901 | 0.990 |
Why?
| | Bronchoalveolar Lavage Fluid | 15 | 2016 | 644 | 0.970 |
Why?
| | Animals | 173 | 2016 | 35286 | 0.930 |
Why?
| | Ferritins | 5 | 2004 | 58 | 0.920 |
Why?
| | Oxygen Inhalation Therapy | 2 | 2016 | 143 | 0.900 |
Why?
| | Xanthine Dehydrogenase | 14 | 1999 | 25 | 0.840 |
Why?
| | Ergothioneine | 2 | 2012 | 2 | 0.780 |
Why?
| | Lipopolysaccharides | 7 | 2015 | 877 | 0.740 |
Why?
| | Blood Bactericidal Activity | 21 | 1992 | 36 | 0.710 |
Why?
| | In Vitro Techniques | 46 | 2002 | 1085 | 0.690 |
Why?
| | Interferon Type I | 1 | 2021 | 139 | 0.680 |
Why?
| | Glutathione | 19 | 2000 | 347 | 0.660 |
Why?
| | Reperfusion Injury | 15 | 1997 | 271 | 0.650 |
Why?
| | Prostaglandins | 3 | 2019 | 93 | 0.650 |
Why?
| | Ischemia | 11 | 1997 | 405 | 0.640 |
Why?
| | Enzyme Inhibitors | 8 | 2004 | 827 | 0.640 |
Why?
| | Persian Gulf Syndrome | 1 | 2019 | 15 | 0.630 |
Why?
| | Chemokines, CXC | 6 | 2005 | 70 | 0.630 |
Why?
| | Leukotrienes | 1 | 2019 | 37 | 0.630 |
Why?
| | Pneumonia | 6 | 2011 | 616 | 0.630 |
Why?
| | Free Radicals | 24 | 2008 | 105 | 0.620 |
Why?
| | Capillary Permeability | 14 | 2002 | 140 | 0.620 |
Why?
| | Pulmonary Alveoli | 23 | 2011 | 400 | 0.610 |
Why?
| | Virus Diseases | 1 | 2021 | 210 | 0.610 |
Why?
| | Dimethyl Sulfoxide | 18 | 1994 | 41 | 0.600 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2021 | 203 | 0.600 |
Why?
| | Aerosols | 4 | 2016 | 170 | 0.600 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2016 | 983 | 0.580 |
Why?
| | Superoxide Dismutase | 27 | 1996 | 342 | 0.580 |
Why?
| | Lung Injury | 9 | 2014 | 210 | 0.570 |
Why?
| | Rats, Inbred Strains | 37 | 1992 | 368 | 0.560 |
Why?
| | Chemotactic Factors | 11 | 1997 | 54 | 0.560 |
Why?
| | Receptors, Cell Surface | 2 | 2015 | 380 | 0.560 |
Why?
| | Intercellular Signaling Peptides and Proteins | 6 | 2005 | 374 | 0.550 |
Why?
| | Cytokines | 8 | 2014 | 2012 | 0.550 |
Why?
| | Oxidants | 6 | 2004 | 109 | 0.540 |
Why?
| | Respiratory Tract Infections | 1 | 2021 | 376 | 0.530 |
Why?
| | Chemotaxis, Leukocyte | 10 | 1997 | 137 | 0.520 |
Why?
| | Malathion | 1 | 2016 | 3 | 0.510 |
Why?
| | Staphylococcus aureus | 29 | 1988 | 434 | 0.510 |
Why?
| | Tetradecanoylphorbol Acetate | 20 | 1994 | 149 | 0.500 |
Why?
| | Capillaries | 2 | 2015 | 103 | 0.480 |
Why?
| | Leukocyte Elastase | 5 | 2002 | 74 | 0.480 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2015 | 59 | 0.480 |
Why?
| | Heme Oxygenase-1 | 1 | 2015 | 62 | 0.480 |
Why?
| | Platelet Activating Factor | 4 | 2002 | 75 | 0.470 |
Why?
| | Glutamine | 1 | 2015 | 99 | 0.470 |
Why?
| | Myocardial Reperfusion Injury | 9 | 1992 | 129 | 0.460 |
Why?
| | Macrophages | 24 | 1991 | 1481 | 0.460 |
Why?
| | Kidney | 11 | 1999 | 1384 | 0.460 |
Why?
| | Respiration, Artificial | 3 | 2015 | 613 | 0.460 |
Why?
| | Phagocytosis | 22 | 2007 | 362 | 0.440 |
Why?
| | Lung Diseases | 10 | 2007 | 739 | 0.440 |
Why?
| | Prostaglandin D2 | 1 | 2013 | 22 | 0.430 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2015 | 311 | 0.430 |
Why?
| | Hemorrhage | 4 | 2004 | 678 | 0.430 |
Why?
| | Quinacrine | 3 | 2004 | 9 | 0.430 |
Why?
| | Perfusion | 22 | 2002 | 197 | 0.420 |
Why?
| | Peroxidase | 15 | 2003 | 174 | 0.420 |
Why?
| | Neutrophil Infiltration | 1 | 2013 | 105 | 0.420 |
Why?
| | Hydroxides | 9 | 1991 | 26 | 0.420 |
Why?
| | Male | 102 | 2019 | 63456 | 0.420 |
Why?
| | Nitric Oxide | 8 | 2014 | 895 | 0.410 |
Why?
| | Antigens, CD | 1 | 2015 | 487 | 0.400 |
Why?
| | L-Lactate Dehydrogenase | 17 | 2013 | 119 | 0.390 |
Why?
| | Allopurinol | 11 | 2003 | 62 | 0.390 |
Why?
| | Myocardium | 14 | 1992 | 978 | 0.390 |
Why?
| | Pulmonary Artery | 13 | 1997 | 1095 | 0.380 |
Why?
| | Serine Proteinase Inhibitors | 4 | 2002 | 43 | 0.370 |
Why?
| | Inflammation | 6 | 2016 | 2735 | 0.370 |
Why?
| | Cell Adhesion | 15 | 2007 | 452 | 0.370 |
Why?
| | Fruit | 1 | 2012 | 131 | 0.360 |
Why?
| | Aldehyde Oxidoreductases | 4 | 1999 | 27 | 0.360 |
Why?
| | Vegetables | 1 | 2012 | 147 | 0.360 |
Why?
| | Rabbits | 29 | 1991 | 777 | 0.350 |
Why?
| | Tumor Necrosis Factor-alpha | 8 | 2005 | 1201 | 0.350 |
Why?
| | Pancreatic Elastase | 8 | 1993 | 60 | 0.350 |
Why?
| | Cells, Cultured | 28 | 2008 | 4075 | 0.350 |
Why?
| | Burns | 4 | 2019 | 286 | 0.350 |
Why?
| | Tungsten | 15 | 2003 | 30 | 0.350 |
Why?
| | Pentoxifylline | 4 | 1997 | 24 | 0.340 |
Why?
| | Pulmonary Circulation | 6 | 2005 | 430 | 0.340 |
Why?
| | Reactive Oxygen Species | 5 | 1999 | 593 | 0.340 |
Why?
| | Humans | 125 | 2021 | 129144 | 0.340 |
Why?
| | Cattle | 18 | 2007 | 977 | 0.330 |
Why?
| | Heart | 10 | 1994 | 637 | 0.320 |
Why?
| | Erythrocytes | 11 | 1995 | 673 | 0.320 |
Why?
| | Oxidation-Reduction | 22 | 1999 | 1028 | 0.310 |
Why?
| | Deferoxamine | 3 | 2002 | 20 | 0.310 |
Why?
| | Tissue Plasminogen Activator | 3 | 2005 | 222 | 0.300 |
Why?
| | Phorbols | 8 | 1986 | 10 | 0.300 |
Why?
| | Vitamin E | 4 | 1998 | 120 | 0.300 |
Why?
| | Soot | 1 | 2008 | 25 | 0.300 |
Why?
| | Biomarkers | 9 | 2019 | 3963 | 0.290 |
Why?
| | Granulomatous Disease, Chronic | 12 | 1988 | 53 | 0.290 |
Why?
| | Gulf War | 2 | 2019 | 14 | 0.290 |
Why?
| | Oxygen Consumption | 19 | 1995 | 672 | 0.290 |
Why?
| | Dietary Supplements | 1 | 2012 | 534 | 0.290 |
Why?
| | Receptors, Interleukin-1 | 4 | 1997 | 218 | 0.290 |
Why?
| | Dinoprost | 2 | 2019 | 44 | 0.280 |
Why?
| | Tyrosine | 2 | 2008 | 222 | 0.270 |
Why?
| | Bacterial Infections | 7 | 1993 | 235 | 0.270 |
Why?
| | Intercellular Adhesion Molecule-1 | 3 | 2007 | 135 | 0.270 |
Why?
| | Phosphatidic Acids | 2 | 1997 | 9 | 0.260 |
Why?
| | Particulate Matter | 1 | 2008 | 246 | 0.260 |
Why?
| | Trachea | 6 | 2005 | 220 | 0.260 |
Why?
| | Blood Platelets | 7 | 1992 | 380 | 0.260 |
Why?
| | Free Radical Scavengers | 8 | 2000 | 82 | 0.250 |
Why?
| | Shock, Septic | 3 | 2000 | 209 | 0.250 |
Why?
| | Leukocytes | 7 | 2007 | 306 | 0.250 |
Why?
| | Endothelium | 10 | 1997 | 121 | 0.250 |
Why?
| | Phagocytes | 2 | 2003 | 97 | 0.250 |
Why?
| | Muscles | 3 | 1991 | 320 | 0.240 |
Why?
| | Recombinant Proteins | 10 | 2005 | 1304 | 0.240 |
Why?
| | alpha-Tocopherol | 1 | 2005 | 33 | 0.240 |
Why?
| | Administration, Inhalation | 5 | 2016 | 666 | 0.230 |
Why?
| | Leukotriene B4 | 3 | 2016 | 42 | 0.230 |
Why?
| | Krypton | 3 | 2011 | 4 | 0.230 |
Why?
| | Obesity | 2 | 2015 | 2879 | 0.230 |
Why?
| | Endotoxins | 7 | 1992 | 220 | 0.230 |
Why?
| | Tidal Volume | 2 | 2015 | 84 | 0.230 |
Why?
| | Growth Substances | 4 | 1997 | 150 | 0.220 |
Why?
| | Coronary Disease | 5 | 1991 | 385 | 0.220 |
Why?
| | Mitochondria | 5 | 2008 | 876 | 0.220 |
Why?
| | Glutathione Peroxidase | 10 | 1994 | 43 | 0.210 |
Why?
| | Postoperative Complications | 1 | 2015 | 2472 | 0.210 |
Why?
| | Skin | 3 | 1995 | 726 | 0.210 |
Why?
| | Leukocyte Count | 8 | 2003 | 326 | 0.210 |
Why?
| | Nitroblue Tetrazolium | 8 | 2000 | 12 | 0.210 |
Why?
| | Acute Kidney Injury | 3 | 1997 | 789 | 0.210 |
Why?
| | Smoking | 7 | 2014 | 1499 | 0.200 |
Why?
| | Intercellular Junctions | 1 | 2002 | 39 | 0.200 |
Why?
| | Cell Count | 4 | 2013 | 311 | 0.200 |
Why?
| | Iron | 8 | 2002 | 281 | 0.200 |
Why?
| | Iron Chelating Agents | 1 | 2002 | 18 | 0.200 |
Why?
| | Environmental Exposure | 2 | 2017 | 462 | 0.200 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2003 | 59 | 0.200 |
Why?
| | Permeability | 7 | 2002 | 156 | 0.200 |
Why?
| | Organ Size | 10 | 1998 | 445 | 0.200 |
Why?
| | Amitrole | 8 | 1990 | 9 | 0.190 |
Why?
| | Dose-Response Relationship, Drug | 7 | 2016 | 2008 | 0.190 |
Why?
| | Edema | 4 | 1997 | 124 | 0.190 |
Why?
| | Particle Size | 3 | 2016 | 351 | 0.190 |
Why?
| | Neutropenia | 5 | 1997 | 136 | 0.190 |
Why?
| | Thromboxanes | 4 | 1988 | 16 | 0.180 |
Why?
| | von Willebrand Factor | 3 | 2019 | 70 | 0.180 |
Why?
| | Corneal Stroma | 1 | 2001 | 17 | 0.180 |
Why?
| | Risk Factors | 9 | 2019 | 9740 | 0.180 |
Why?
| | Glycine | 1 | 2002 | 165 | 0.180 |
Why?
| | Administration, Intranasal | 1 | 2021 | 84 | 0.180 |
Why?
| | Intubation, Intratracheal | 6 | 2002 | 239 | 0.180 |
Why?
| | Photorefractive Keratectomy | 1 | 2001 | 19 | 0.180 |
Why?
| | Air Pollutants, Occupational | 1 | 2001 | 32 | 0.180 |
Why?
| | Sodium | 2 | 1999 | 205 | 0.180 |
Why?
| | Transforming Growth Factor beta | 1 | 2003 | 455 | 0.180 |
Why?
| | Renal Circulation | 4 | 1997 | 57 | 0.170 |
Why?
| | Chromosomes, Human, Pair 2 | 2 | 1997 | 28 | 0.170 |
Why?
| | Nitrates | 2 | 2017 | 88 | 0.170 |
Why?
| | Acute Disease | 8 | 1999 | 978 | 0.170 |
Why?
| | Indicators and Reagents | 6 | 2000 | 109 | 0.170 |
Why?
| | Phagocyte Bactericidal Dysfunction | 5 | 1979 | 12 | 0.170 |
Why?
| | Saccharomyces cerevisiae | 3 | 1995 | 530 | 0.160 |
Why?
| | Kinetics | 12 | 1996 | 1643 | 0.160 |
Why?
| | Sialoglycoproteins | 2 | 1997 | 155 | 0.160 |
Why?
| | Chemokine CXCL1 | 4 | 2005 | 72 | 0.160 |
Why?
| | Alcohol Dehydrogenase | 1 | 1999 | 16 | 0.160 |
Why?
| | Lactoferrin | 2 | 2017 | 28 | 0.160 |
Why?
| | Physical Exertion | 1 | 2000 | 205 | 0.160 |
Why?
| | Female | 32 | 2019 | 68494 | 0.150 |
Why?
| | Triazoles | 3 | 2002 | 148 | 0.150 |
Why?
| | Luminescent Measurements | 8 | 1997 | 75 | 0.150 |
Why?
| | Interleukin-8 | 3 | 1997 | 262 | 0.150 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2000 | 207 | 0.150 |
Why?
| | Multiple Trauma | 1 | 1999 | 101 | 0.150 |
Why?
| | Monocytes | 7 | 2007 | 551 | 0.150 |
Why?
| | Sulfonamides | 1 | 2002 | 495 | 0.150 |
Why?
| | Brain Edema | 2 | 1990 | 60 | 0.150 |
Why?
| | Kidney Tubules, Proximal | 1 | 1999 | 125 | 0.150 |
Why?
| | Alprostadil | 2 | 1997 | 32 | 0.150 |
Why?
| | Acetylcysteine | 3 | 1995 | 146 | 0.140 |
Why?
| | Molybdenum | 1 | 1997 | 9 | 0.140 |
Why?
| | Veterans Health | 1 | 2019 | 177 | 0.140 |
Why?
| | Lung Diseases, Obstructive | 1 | 1997 | 46 | 0.140 |
Why?
| | Chronic Disease | 3 | 2014 | 1714 | 0.140 |
Why?
| | Polyethylene Glycols | 5 | 1990 | 587 | 0.130 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2011 | 537 | 0.130 |
Why?
| | Phospholipases A | 1 | 1997 | 99 | 0.130 |
Why?
| | Therapeutic Irrigation | 7 | 1997 | 75 | 0.130 |
Why?
| | Neutrophil Activation | 1 | 1997 | 79 | 0.130 |
Why?
| | Chromatography, Affinity | 1 | 1996 | 83 | 0.130 |
Why?
| | DNA Damage | 1 | 1999 | 382 | 0.130 |
Why?
| | Sepsis | 2 | 2000 | 572 | 0.130 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 1996 | 161 | 0.130 |
Why?
| | Fatty Acids, Unsaturated | 1 | 1996 | 97 | 0.120 |
Why?
| | Fatty Acids, Nonesterified | 1 | 1996 | 160 | 0.120 |
Why?
| | Carbonates | 1 | 1995 | 10 | 0.120 |
Why?
| | One-Lung Ventilation | 1 | 2015 | 2 | 0.120 |
Why?
| | Menstruation | 2 | 1986 | 44 | 0.120 |
Why?
| | Adjuvants, Immunologic | 1 | 1997 | 221 | 0.120 |
Why?
| | Hypoxia | 3 | 2015 | 1084 | 0.120 |
Why?
| | Ethanol | 2 | 1999 | 589 | 0.120 |
Why?
| | Pulmonary Surfactants | 3 | 2007 | 106 | 0.120 |
Why?
| | Mice, Inbred Strains | 1 | 2016 | 406 | 0.120 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 832 | 0.120 |
Why?
| | Sodium Bicarbonate | 1 | 1995 | 37 | 0.120 |
Why?
| | Predictive Value of Tests | 5 | 2019 | 1943 | 0.120 |
Why?
| | Vitamin E Deficiency | 1 | 1995 | 43 | 0.120 |
Why?
| | Interleukin-10 | 1 | 1997 | 300 | 0.120 |
Why?
| | Vinblastine | 6 | 1997 | 70 | 0.120 |
Why?
| | Serum Albumin | 4 | 1994 | 148 | 0.120 |
Why?
| | Muscle, Smooth, Vascular | 2 | 1997 | 443 | 0.120 |
Why?
| | Critical Care | 1 | 2000 | 551 | 0.120 |
Why?
| | Glutathione Disulfide | 5 | 1994 | 32 | 0.120 |
Why?
| | Positive-Pressure Respiration | 1 | 2015 | 76 | 0.120 |
Why?
| | Oligonucleotides | 1 | 1995 | 140 | 0.120 |
Why?
| | Arachidonate 5-Lipoxygenase | 1 | 1994 | 42 | 0.110 |
Why?
| | Vasoconstriction | 3 | 1988 | 199 | 0.110 |
Why?
| | Reperfusion | 2 | 1992 | 38 | 0.110 |
Why?
| | Case-Control Studies | 2 | 2019 | 3372 | 0.110 |
Why?
| | Carbon Dioxide | 2 | 1995 | 259 | 0.110 |
Why?
| | Cell Movement | 6 | 1996 | 944 | 0.110 |
Why?
| | Liposomes | 3 | 1997 | 171 | 0.110 |
Why?
| | Liver | 2 | 2000 | 1839 | 0.110 |
Why?
| | Insufflation | 1 | 2013 | 11 | 0.110 |
Why?
| | Granulocytes | 3 | 1982 | 77 | 0.110 |
Why?
| | Perioperative Care | 1 | 2015 | 151 | 0.110 |
Why?
| | Hemolysis | 2 | 1993 | 199 | 0.110 |
Why?
| | Oligopeptides | 2 | 1992 | 258 | 0.110 |
Why?
| | Smoke | 2 | 2007 | 139 | 0.100 |
Why?
| | Molecular Sequence Data | 6 | 1999 | 2835 | 0.100 |
Why?
| | Purines | 4 | 2002 | 172 | 0.100 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2736 | 0.100 |
Why?
| | Hydroxyl Radical | 7 | 1991 | 91 | 0.100 |
Why?
| | Hypertension, Pulmonary | 5 | 1987 | 1894 | 0.100 |
Why?
| | Pleural Effusion | 4 | 1992 | 51 | 0.100 |
Why?
| | Sulfhydryl Compounds | 3 | 1992 | 187 | 0.100 |
Why?
| | Serpins | 1 | 1992 | 31 | 0.100 |
Why?
| | Microscopy, Electron | 6 | 2000 | 426 | 0.100 |
Why?
| | Glucose Oxidase | 3 | 1987 | 26 | 0.100 |
Why?
| | Tetrazolium Salts | 5 | 1991 | 17 | 0.100 |
Why?
| | Acute Lung Injury | 1 | 2015 | 279 | 0.100 |
Why?
| | Opsonin Proteins | 7 | 1988 | 25 | 0.100 |
Why?
| | Escherichia coli | 4 | 1988 | 766 | 0.090 |
Why?
| | Disease Susceptibility | 1 | 2014 | 332 | 0.090 |
Why?
| | Respiration | 3 | 2001 | 191 | 0.090 |
Why?
| | Complement C2 | 4 | 1979 | 7 | 0.090 |
Why?
| | Inhalation | 1 | 2011 | 28 | 0.090 |
Why?
| | Melanocytes | 1 | 1991 | 64 | 0.090 |
Why?
| | Azepines | 2 | 2002 | 88 | 0.090 |
Why?
| | Salmonella typhimurium | 2 | 1991 | 174 | 0.090 |
Why?
| | Cell Hypoxia | 1 | 1992 | 234 | 0.090 |
Why?
| | N-Formylmethionine Leucyl-Phenylalanine | 3 | 1997 | 55 | 0.090 |
Why?
| | Oxidoreductases | 1 | 1991 | 92 | 0.090 |
Why?
| | Leukocytes, Mononuclear | 2 | 1991 | 545 | 0.090 |
Why?
| | Muramidase | 3 | 1988 | 77 | 0.090 |
Why?
| | Middle Aged | 10 | 2019 | 31050 | 0.090 |
Why?
| | Adult | 22 | 2019 | 35469 | 0.090 |
Why?
| | Brain | 3 | 1992 | 2668 | 0.090 |
Why?
| | Phosphorylation | 1 | 2015 | 1710 | 0.090 |
Why?
| | Electron Spin Resonance Spectroscopy | 2 | 2008 | 91 | 0.090 |
Why?
| | Xenon Isotopes | 2 | 2007 | 3 | 0.090 |
Why?
| | Shock | 1 | 1991 | 92 | 0.090 |
Why?
| | Diterpenes | 3 | 1975 | 32 | 0.090 |
Why?
| | Base Sequence | 5 | 1999 | 2146 | 0.090 |
Why?
| | Riboflavin | 1 | 1990 | 7 | 0.090 |
Why?
| | Diabetes Mellitus | 2 | 2014 | 1000 | 0.080 |
Why?
| | Paraquat | 1 | 1990 | 14 | 0.080 |
Why?
| | Fibroblasts | 3 | 1991 | 947 | 0.080 |
Why?
| | Glycoconjugates | 1 | 1990 | 8 | 0.080 |
Why?
| | Keratinocytes | 1 | 1991 | 242 | 0.080 |
Why?
| | Blood Cells | 1 | 1990 | 39 | 0.080 |
Why?
| | Arachidonic Acids | 1 | 1990 | 59 | 0.080 |
Why?
| | Factor VII | 1 | 1989 | 22 | 0.080 |
Why?
| | Hyperbaric Oxygenation | 2 | 1987 | 38 | 0.080 |
Why?
| | Aldehyde Oxidase | 3 | 1999 | 3 | 0.080 |
Why?
| | Reference Values | 4 | 1997 | 793 | 0.080 |
Why?
| | Substrate Specificity | 3 | 1996 | 368 | 0.080 |
Why?
| | Intestines | 1 | 1992 | 347 | 0.080 |
Why?
| | Alkaline Phosphatase | 3 | 1986 | 146 | 0.080 |
Why?
| | RNA | 1 | 1995 | 880 | 0.080 |
Why?
| | Mycobacterium bovis | 3 | 1985 | 16 | 0.080 |
Why?
| | Metals | 1 | 1990 | 123 | 0.080 |
Why?
| | Biological Factors | 1 | 1989 | 36 | 0.080 |
Why?
| | Krypton Radioisotopes | 1 | 2008 | 1 | 0.080 |
Why?
| | RNA, Messenger | 4 | 2005 | 2699 | 0.080 |
Why?
| | Time Factors | 10 | 2000 | 6541 | 0.080 |
Why?
| | Exercise | 1 | 2000 | 1925 | 0.080 |
Why?
| | Myocardial Reperfusion | 4 | 1994 | 50 | 0.080 |
Why?
| | Superantigens | 1 | 1988 | 70 | 0.080 |
Why?
| | Enterotoxins | 1 | 1988 | 87 | 0.080 |
Why?
| | Mice | 5 | 2016 | 16905 | 0.080 |
Why?
| | Thromboxane B2 | 2 | 1988 | 26 | 0.070 |
Why?
| | Antigens | 2 | 1989 | 356 | 0.070 |
Why?
| | Amino Acid Sequence | 3 | 1999 | 2056 | 0.070 |
Why?
| | Nitroarginine | 2 | 1999 | 57 | 0.070 |
Why?
| | Proteins | 5 | 1997 | 941 | 0.070 |
Why?
| | Blood Pressure | 6 | 1995 | 1736 | 0.070 |
Why?
| | Nitroprusside | 2 | 1999 | 67 | 0.070 |
Why?
| | Bacterial Toxins | 1 | 1988 | 104 | 0.070 |
Why?
| | Inhalation Exposure | 1 | 2008 | 91 | 0.070 |
Why?
| | Integrin alpha4beta1 | 1 | 2007 | 7 | 0.070 |
Why?
| | Lymphocyte Function-Associated Antigen-1 | 1 | 2007 | 30 | 0.070 |
Why?
| | Image Enhancement | 1 | 2008 | 167 | 0.070 |
Why?
| | Epithelial Cells | 2 | 2007 | 1064 | 0.070 |
Why?
| | Creatine Kinase | 3 | 2000 | 73 | 0.070 |
Why?
| | Bronchoalveolar Lavage | 2 | 1998 | 92 | 0.070 |
Why?
| | Glomerular Filtration Rate | 4 | 1997 | 711 | 0.070 |
Why?
| | Phospholipids | 2 | 2000 | 215 | 0.070 |
Why?
| | Nylons | 3 | 1984 | 20 | 0.070 |
Why?
| | Alcoholism | 1 | 2014 | 765 | 0.070 |
Why?
| | Zymosan | 5 | 1990 | 65 | 0.070 |
Why?
| | Glucosephosphate Dehydrogenase | 3 | 1994 | 56 | 0.070 |
Why?
| | Complement Activation | 3 | 1995 | 381 | 0.070 |
Why?
| | Disease | 2 | 2017 | 95 | 0.070 |
Why?
| | Breast Neoplasms | 1 | 1999 | 2127 | 0.070 |
Why?
| | Thromboxane A2 | 2 | 1983 | 11 | 0.070 |
Why?
| | Ischemic Attack, Transient | 1 | 1987 | 60 | 0.070 |
Why?
| | Cell Separation | 2 | 1997 | 316 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 2 | 2008 | 3386 | 0.060 |
Why?
| | DNA, Complementary | 2 | 1999 | 270 | 0.060 |
Why?
| | Cell Division | 2 | 1985 | 796 | 0.060 |
Why?
| | Arginine | 2 | 1998 | 263 | 0.060 |
Why?
| | Sequence Homology, Amino Acid | 2 | 1999 | 372 | 0.060 |
Why?
| | Cytochrome c Group | 3 | 1994 | 42 | 0.060 |
Why?
| | Menstrual Cycle | 1 | 1986 | 121 | 0.060 |
Why?
| | Polymerase Chain Reaction | 3 | 1999 | 1033 | 0.060 |
Why?
| | NF-kappa B | 2 | 2002 | 663 | 0.060 |
Why?
| | Contrast Media | 1 | 2008 | 393 | 0.060 |
Why?
| | Peptidyl-Dipeptidase A | 2 | 1985 | 52 | 0.060 |
Why?
| | Cloning, Molecular | 2 | 1999 | 525 | 0.060 |
Why?
| | HEPES | 1 | 1985 | 2 | 0.060 |
Why?
| | Glycoproteins | 1 | 1987 | 338 | 0.060 |
Why?
| | Cerebrovascular Circulation | 1 | 1987 | 227 | 0.060 |
Why?
| | Agranulocytosis | 2 | 1982 | 30 | 0.060 |
Why?
| | Drug Carriers | 2 | 1997 | 119 | 0.060 |
Why?
| | Isotopes | 3 | 2011 | 32 | 0.060 |
Why?
| | Models, Biological | 4 | 2011 | 1722 | 0.060 |
Why?
| | Staphylococcal Infections | 2 | 1986 | 389 | 0.060 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 2 | 1997 | 252 | 0.060 |
Why?
| | Peroxidases | 2 | 1991 | 33 | 0.060 |
Why?
| | Spectrophotometry, Ultraviolet | 2 | 2017 | 84 | 0.060 |
Why?
| | Mesocricetus | 2 | 1995 | 37 | 0.050 |
Why?
| | Mannitol | 4 | 1991 | 38 | 0.050 |
Why?
| | Enzyme Induction | 1 | 2003 | 90 | 0.050 |
Why?
| | Kidney Diseases | 1 | 1987 | 382 | 0.050 |
Why?
| | Genetic Therapy | 1 | 2005 | 288 | 0.050 |
Why?
| | Tuberculoma | 1 | 1983 | 2 | 0.050 |
Why?
| | Lidocaine | 3 | 1987 | 41 | 0.050 |
Why?
| | Aspirin | 2 | 1984 | 380 | 0.050 |
Why?
| | Iron, Dietary | 1 | 2003 | 21 | 0.050 |
Why?
| | Cricetinae | 2 | 1995 | 278 | 0.050 |
Why?
| | Vasodilator Agents | 2 | 1999 | 326 | 0.050 |
Why?
| | Osmolar Concentration | 3 | 1994 | 166 | 0.050 |
Why?
| | Methylprednisolone | 1 | 1983 | 83 | 0.050 |
Why?
| | Carrier Proteins | 2 | 1997 | 742 | 0.050 |
Why?
| | Thiobarbituric Acid Reactive Substances | 1 | 2002 | 31 | 0.050 |
Why?
| | Tetracaine | 2 | 1979 | 4 | 0.050 |
Why?
| | Piperazines | 1 | 1985 | 340 | 0.050 |
Why?
| | Drug Delivery Systems | 1 | 2005 | 332 | 0.050 |
Why?
| | Cryptococcus | 1 | 1982 | 8 | 0.050 |
Why?
| | Hematocrit | 3 | 1992 | 93 | 0.050 |
Why?
| | Blastomycosis | 2 | 1981 | 10 | 0.050 |
Why?
| | Leukemia, Myeloid | 2 | 1979 | 45 | 0.050 |
Why?
| | Cryptococcus neoformans | 1 | 1982 | 19 | 0.050 |
Why?
| | Chediak-Higashi Syndrome | 2 | 1979 | 7 | 0.050 |
Why?
| | Xanthogranuloma, Juvenile | 1 | 1982 | 5 | 0.050 |
Why?
| | Pyelonephritis | 1 | 1982 | 10 | 0.050 |
Why?
| | Tuberculosis, Pulmonary | 1 | 1983 | 135 | 0.050 |
Why?
| | Disease Models, Animal | 3 | 1998 | 4056 | 0.050 |
Why?
| | Chromatography, Gas | 3 | 1988 | 32 | 0.050 |
Why?
| | Nitrogen Mustard Compounds | 1 | 1981 | 6 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 3 | 1995 | 541 | 0.050 |
Why?
| | Signal Transduction | 1 | 1995 | 4919 | 0.050 |
Why?
| | Environmental Pollution | 1 | 2001 | 18 | 0.050 |
Why?
| | Volatilization | 1 | 2001 | 55 | 0.050 |
Why?
| | DNA, Superhelical | 1 | 1981 | 11 | 0.050 |
Why?
| | Complement Pathway, Alternative | 1 | 1982 | 119 | 0.040 |
Why?
| | Lasers, Excimer | 1 | 2001 | 29 | 0.040 |
Why?
| | 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 2 | 1992 | 8 | 0.040 |
Why?
| | 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 2 | 1992 | 12 | 0.040 |
Why?
| | Prospective Studies | 3 | 2019 | 7117 | 0.040 |
Why?
| | Mycoses | 1 | 1981 | 71 | 0.040 |
Why?
| | Microscopy, Electron, Scanning | 4 | 1990 | 196 | 0.040 |
Why?
| | Urea | 3 | 1990 | 76 | 0.040 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 2000 | 35 | 0.040 |
Why?
| | Malondialdehyde | 1 | 2000 | 28 | 0.040 |
Why?
| | Glucose | 8 | 1980 | 1000 | 0.040 |
Why?
| | DNA Primers | 2 | 1999 | 510 | 0.040 |
Why?
| | Sensitivity and Specificity | 2 | 1997 | 1833 | 0.040 |
Why?
| | Organ Preservation | 2 | 1991 | 94 | 0.040 |
Why?
| | Interferon-gamma | 1 | 2003 | 772 | 0.040 |
Why?
| | Aspartate Aminotransferases | 1 | 2000 | 88 | 0.040 |
Why?
| | Ethylenes | 1 | 1979 | 12 | 0.040 |
Why?
| | Methylurea Compounds | 2 | 1994 | 7 | 0.040 |
Why?
| | 6-Aminonicotinamide | 2 | 1990 | 2 | 0.040 |
Why?
| | Glutathione Reductase | 2 | 1990 | 24 | 0.040 |
Why?
| | Chemical Phenomena | 2 | 1995 | 82 | 0.040 |
Why?
| | DNA, Single-Stranded | 1 | 1981 | 113 | 0.040 |
Why?
| | Coronary Circulation | 3 | 1991 | 138 | 0.040 |
Why?
| | Hot Temperature | 3 | 1994 | 368 | 0.040 |
Why?
| | Premedication | 3 | 1985 | 42 | 0.040 |
Why?
| | Biological Transport | 2 | 1999 | 403 | 0.040 |
Why?
| | Chemotaxis | 2 | 1979 | 129 | 0.040 |
Why?
| | Bradykinin | 1 | 1999 | 45 | 0.040 |
Why?
| | Radioimmunoassay | 2 | 1997 | 175 | 0.040 |
Why?
| | Cyclic GMP | 1 | 1999 | 90 | 0.040 |
Why?
| | Chromosome Mapping | 2 | 1997 | 504 | 0.040 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 1999 | 51 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2000 | 441 | 0.040 |
Why?
| | DNA, Viral | 1 | 1981 | 347 | 0.040 |
Why?
| | Albumins | 3 | 1991 | 103 | 0.040 |
Why?
| | Hyperoxia | 1 | 1999 | 90 | 0.040 |
Why?
| | Instillation, Drug | 1 | 1998 | 9 | 0.040 |
Why?
| | Anesthetics, Local | 1 | 1979 | 75 | 0.040 |
Why?
| | Myocardial Contraction | 3 | 1989 | 335 | 0.040 |
Why?
| | Gerbillinae | 2 | 1990 | 64 | 0.040 |
Why?
| | Myocardial Infarction | 3 | 1991 | 1021 | 0.040 |
Why?
| | Culture Techniques | 2 | 1992 | 81 | 0.040 |
Why?
| | Coculture Techniques | 1 | 1999 | 223 | 0.040 |
Why?
| | Injections, Intraperitoneal | 1 | 1998 | 111 | 0.040 |
Why?
| | Acetylcholine | 1 | 1999 | 183 | 0.040 |
Why?
| | Pulmonary Ventilation | 2 | 2011 | 77 | 0.040 |
Why?
| | Levamisole | 1 | 1977 | 19 | 0.040 |
Why?
| | Cloning, Organism | 1 | 1997 | 6 | 0.040 |
Why?
| | Linoleic Acid | 1 | 1997 | 41 | 0.040 |
Why?
| | Oleic Acid | 1 | 1997 | 39 | 0.040 |
Why?
| | Phospholipases A2 | 1 | 1997 | 79 | 0.030 |
Why?
| | Muscle Contraction | 2 | 1990 | 422 | 0.030 |
Why?
| | Spectrometry, Fluorescence | 1 | 2017 | 163 | 0.030 |
Why?
| | Methane | 3 | 1983 | 47 | 0.030 |
Why?
| | Electron Transport | 2 | 1995 | 112 | 0.030 |
Why?
| | HIV Infections | 1 | 1992 | 2721 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2001 | 503 | 0.030 |
Why?
| | Amino Acid Chloromethyl Ketones | 1 | 1997 | 25 | 0.030 |
Why?
| | NADP | 2 | 1988 | 46 | 0.030 |
Why?
| | Absorption | 1 | 1997 | 57 | 0.030 |
Why?
| | Complement System Proteins | 2 | 1977 | 317 | 0.030 |
Why?
| | Injury Severity Score | 1 | 1999 | 509 | 0.030 |
Why?
| | Tumor Necrosis Factor Decoy Receptors | 1 | 1996 | 8 | 0.030 |
Why?
| | Aged | 5 | 2019 | 21997 | 0.030 |
Why?
| | Benzamidines | 1 | 1996 | 3 | 0.030 |
Why?
| | Isoelectric Point | 1 | 1996 | 23 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 1990 | 580 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2003 | 1363 | 0.030 |
Why?
| | Xanthines | 1 | 1996 | 19 | 0.030 |
Why?
| | Hydrolysis | 1 | 1997 | 186 | 0.030 |
Why?
| | Immunoassay | 1 | 1997 | 107 | 0.030 |
Why?
| | Sepharose | 1 | 1996 | 33 | 0.030 |
Why?
| | Blood Proteins | 1 | 1978 | 244 | 0.030 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 1996 | 86 | 0.030 |
Why?
| | Sodium Chloride | 2 | 1990 | 137 | 0.030 |
Why?
| | Endocarditis, Bacterial | 1 | 1976 | 42 | 0.030 |
Why?
| | Interleukin-4 | 1 | 1997 | 212 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 1998 | 767 | 0.030 |
Why?
| | Adenine | 2 | 1997 | 256 | 0.030 |
Why?
| | Diet | 4 | 1995 | 1212 | 0.030 |
Why?
| | Cathepsin G | 1 | 1995 | 6 | 0.030 |
Why?
| | Chemistry, Physical | 1 | 1995 | 37 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2003 | 1888 | 0.030 |
Why?
| | Cathepsins | 1 | 1995 | 24 | 0.030 |
Why?
| | Injections | 1 | 1996 | 174 | 0.030 |
Why?
| | Hydrochloric Acid | 1 | 1995 | 9 | 0.030 |
Why?
| | Single-Blind Method | 1 | 1996 | 271 | 0.030 |
Why?
| | Sex Chromosomes | 1 | 1975 | 50 | 0.030 |
Why?
| | Cross Reactions | 1 | 1995 | 132 | 0.030 |
Why?
| | Isoenzymes | 1 | 1996 | 301 | 0.030 |
Why?
| | Injections, Spinal | 1 | 1995 | 104 | 0.030 |
Why?
| | ROC Curve | 1 | 1997 | 502 | 0.030 |
Why?
| | Erythrocyte Indices | 1 | 1995 | 27 | 0.030 |
Why?
| | Factor VIII | 2 | 1993 | 87 | 0.030 |
Why?
| | Serine Endopeptidases | 1 | 1995 | 118 | 0.030 |
Why?
| | Adolescent | 8 | 1999 | 20297 | 0.030 |
Why?
| | Cytosol | 1 | 1995 | 219 | 0.030 |
Why?
| | Uteroglobin | 1 | 2014 | 23 | 0.030 |
Why?
| | Acyltransferases | 1 | 1995 | 55 | 0.030 |
Why?
| | Tuberculosis, Pleural | 2 | 1985 | 6 | 0.030 |
Why?
| | United States | 1 | 2011 | 13825 | 0.030 |
Why?
| | Croton Oil | 1 | 1974 | 3 | 0.030 |
Why?
| | Hydroxyurea | 1 | 1994 | 34 | 0.030 |
Why?
| | Lipoxygenase Inhibitors | 1 | 1994 | 38 | 0.030 |
Why?
| | Drug Tolerance | 1 | 1994 | 90 | 0.030 |
Why?
| | Apoptosis | 1 | 2003 | 2491 | 0.030 |
Why?
| | Leukotriene Antagonists | 1 | 1994 | 43 | 0.030 |
Why?
| | Ficoll | 1 | 1994 | 5 | 0.030 |
Why?
| | Nitrites | 1 | 2014 | 83 | 0.030 |
Why?
| | C-Reactive Protein | 1 | 1997 | 400 | 0.030 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 1995 | 68 | 0.030 |
Why?
| | Anions | 3 | 1995 | 31 | 0.030 |
Why?
| | Enzyme Activation | 3 | 1991 | 812 | 0.030 |
Why?
| | Serum Albumin, Radio-Iodinated | 1 | 1994 | 6 | 0.030 |
Why?
| | Drug Combinations | 1 | 1995 | 330 | 0.030 |
Why?
| | Methods | 2 | 1984 | 64 | 0.030 |
Why?
| | Breath Tests | 1 | 1994 | 87 | 0.030 |
Why?
| | Dogs | 6 | 1991 | 382 | 0.030 |
Why?
| | Restriction Mapping | 1 | 1993 | 75 | 0.030 |
Why?
| | Pressure | 2 | 1986 | 237 | 0.030 |
Why?
| | Diptera | 1 | 1993 | 29 | 0.030 |
Why?
| | Stomach | 1 | 1994 | 109 | 0.030 |
Why?
| | Haploidy | 1 | 1993 | 24 | 0.030 |
Why?
| | Genes | 1 | 1993 | 227 | 0.030 |
Why?
| | Clinical Enzyme Tests | 1 | 1993 | 10 | 0.030 |
Why?
| | Myocardial Ischemia | 1 | 1994 | 258 | 0.030 |
Why?
| | Sequence Alignment | 1 | 1993 | 332 | 0.030 |
Why?
| | Shock, Hemorrhagic | 1 | 1995 | 165 | 0.030 |
Why?
| | Epoprostenol | 2 | 1991 | 136 | 0.030 |
Why?
| | Hemoglobins | 1 | 1995 | 339 | 0.020 |
Why?
| | Platelet Count | 2 | 1984 | 82 | 0.020 |
Why?
| | Drosophila | 1 | 1993 | 140 | 0.020 |
Why?
| | Chromium | 1 | 1992 | 13 | 0.020 |
Why?
| | Biomechanical Phenomena | 2 | 1987 | 757 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 1992 | 202 | 0.020 |
Why?
| | Survival Rate | 1 | 1997 | 1869 | 0.020 |
Why?
| | Membrane Proteins | 1 | 1978 | 1116 | 0.020 |
Why?
| | Gene Expression | 2 | 1995 | 1463 | 0.020 |
Why?
| | Glucosephosphates | 1 | 1991 | 3 | 0.020 |
Why?
| | Glucose-6-Phosphate | 1 | 1991 | 6 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2019 | 3077 | 0.020 |
Why?
| | Elapid Venoms | 1 | 1991 | 17 | 0.020 |
Why?
| | Mechlorethamine | 2 | 1982 | 63 | 0.020 |
Why?
| | Double-Blind Method | 1 | 1996 | 1874 | 0.020 |
Why?
| | Disease Progression | 1 | 1999 | 2622 | 0.020 |
Why?
| | Indoles | 1 | 1994 | 383 | 0.020 |
Why?
| | Ethylmaleimide | 2 | 1989 | 18 | 0.020 |
Why?
| | Pentetic Acid | 1 | 1991 | 13 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 1995 | 848 | 0.020 |
Why?
| | Sodium Azide | 1 | 1990 | 4 | 0.020 |
Why?
| | Ventricular Function | 1 | 1991 | 61 | 0.020 |
Why?
| | Formaldehyde | 1 | 1991 | 60 | 0.020 |
Why?
| | Azides | 1 | 1990 | 46 | 0.020 |
Why?
| | Alcohols | 3 | 1975 | 29 | 0.020 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 1992 | 227 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2000 | 1613 | 0.020 |
Why?
| | Edetic Acid | 1 | 1990 | 46 | 0.020 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2014 | 305 | 0.020 |
Why?
| | Arteries | 2 | 1988 | 265 | 0.020 |
Why?
| | Guinea Pigs | 1 | 1990 | 157 | 0.020 |
Why?
| | Organ Culture Techniques | 1 | 1990 | 153 | 0.020 |
Why?
| | Brain Chemistry | 1 | 1990 | 118 | 0.020 |
Why?
| | Body Weight | 1 | 1994 | 939 | 0.020 |
Why?
| | Wounds and Injuries | 1 | 1996 | 710 | 0.020 |
Why?
| | Methionine | 1 | 1990 | 155 | 0.020 |
Why?
| | Enzyme Stability | 2 | 2005 | 69 | 0.020 |
Why?
| | Analysis of Variance | 1 | 1992 | 1288 | 0.020 |
Why?
| | Heart Arrest, Induced | 1 | 1989 | 31 | 0.020 |
Why?
| | Cell Survival | 2 | 1990 | 1074 | 0.020 |
Why?
| | Catalysis | 1 | 1990 | 307 | 0.020 |
Why?
| | Streptococcus pneumoniae | 2 | 1981 | 159 | 0.020 |
Why?
| | Carmustine | 1 | 1988 | 50 | 0.020 |
Why?
| | Epithelium | 1 | 1990 | 311 | 0.020 |
Why?
| | Pentose Phosphate Pathway | 1 | 1988 | 50 | 0.020 |
Why?
| | Biological Assay | 2 | 1981 | 118 | 0.020 |
Why?
| | Campylobacter fetus | 1 | 1988 | 1 | 0.020 |
Why?
| | Protamines | 1 | 1988 | 7 | 0.020 |
Why?
| | Prognosis | 1 | 1997 | 3766 | 0.020 |
Why?
| | Campylobacter Infections | 1 | 1988 | 16 | 0.020 |
Why?
| | Temperature | 2 | 1983 | 635 | 0.020 |
Why?
| | Interleukin-2 | 1 | 1989 | 437 | 0.020 |
Why?
| | Papaverine | 1 | 1987 | 2 | 0.020 |
Why?
| | Microbial Collagenase | 1 | 1987 | 12 | 0.020 |
Why?
| | Organ Specificity | 1 | 1988 | 295 | 0.020 |
Why?
| | Helium | 1 | 2007 | 6 | 0.020 |
Why?
| | Antimycin A | 2 | 1995 | 13 | 0.020 |
Why?
| | Tissue Fixation | 1 | 2007 | 33 | 0.020 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2007 | 37 | 0.020 |
Why?
| | Follow-Up Studies | 2 | 1986 | 4882 | 0.020 |
Why?
| | Nicotine | 1 | 1990 | 302 | 0.020 |
Why?
| | Constriction | 1 | 1987 | 45 | 0.020 |
Why?
| | Hemiplegia | 1 | 1987 | 21 | 0.020 |
Why?
| | Fatty Acids | 3 | 1975 | 426 | 0.020 |
Why?
| | Membranes | 1 | 1987 | 20 | 0.020 |
Why?
| | Anti-Arrhythmia Agents | 1 | 1987 | 111 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2007 | 327 | 0.020 |
Why?
| | Heart Ventricles | 2 | 1989 | 781 | 0.020 |
Why?
| | Complement C3 | 1 | 1988 | 208 | 0.020 |
Why?
| | Phantoms, Imaging | 1 | 2007 | 137 | 0.020 |
Why?
| | Regional Blood Flow | 1 | 1988 | 463 | 0.020 |
Why?
| | Brain Ischemia | 1 | 1990 | 321 | 0.020 |
Why?
| | Cell Membrane | 3 | 1978 | 732 | 0.020 |
Why?
| | Carboxypeptidases | 1 | 1985 | 13 | 0.020 |
Why?
| | Drug Synergism | 1 | 1986 | 370 | 0.020 |
Why?
| | Tissue Adhesions | 1 | 1985 | 30 | 0.020 |
Why?
| | Surface Properties | 1 | 2007 | 397 | 0.020 |
Why?
| | Carotid Arteries | 1 | 1987 | 196 | 0.020 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2005 | 107 | 0.010 |
Why?
| | Sneezing | 1 | 1985 | 1 | 0.010 |
Why?
| | Granuloma | 1 | 1985 | 89 | 0.010 |
Why?
| | Lipid Peroxides | 1 | 1985 | 11 | 0.010 |
Why?
| | Cell Communication | 1 | 1987 | 300 | 0.010 |
Why?
| | Respiratory Physiological Phenomena | 1 | 1985 | 30 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 1987 | 478 | 0.010 |
Why?
| | Sheep | 2 | 1988 | 838 | 0.010 |
Why?
| | Blotting, Western | 1 | 2007 | 1202 | 0.010 |
Why?
| | Rheology | 1 | 1985 | 90 | 0.010 |
Why?
| | Hemodynamics | 4 | 1991 | 1090 | 0.010 |
Why?
| | Mucous Membrane | 1 | 1985 | 122 | 0.010 |
Why?
| | Pleurisy | 1 | 1983 | 5 | 0.010 |
Why?
| | Blood Glucose | 4 | 1983 | 2098 | 0.010 |
Why?
| | Cyanamide | 1 | 1983 | 1 | 0.010 |
Why?
| | Singlet Oxygen | 1 | 1984 | 18 | 0.010 |
Why?
| | Cough | 1 | 1985 | 116 | 0.010 |
Why?
| | Radiation Injuries, Experimental | 1 | 1983 | 23 | 0.010 |
Why?
| | Dietary Proteins | 1 | 1985 | 129 | 0.010 |
Why?
| | Respiratory System | 1 | 1985 | 154 | 0.010 |
Why?
| | Behavior, Animal | 1 | 1987 | 505 | 0.010 |
Why?
| | Bacteria | 2 | 1981 | 813 | 0.010 |
Why?
| | Molecular Weight | 1 | 1983 | 328 | 0.010 |
Why?
| | Prostanoic Acids | 1 | 1983 | 1 | 0.010 |
Why?
| | BCG Vaccine | 1 | 1983 | 24 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2007 | 1678 | 0.010 |
Why?
| | Immunization | 1 | 1985 | 411 | 0.010 |
Why?
| | Immunity, Cellular | 1 | 1985 | 265 | 0.010 |
Why?
| | Mammals | 1 | 1985 | 272 | 0.010 |
Why?
| | Fibrinolytic Agents | 1 | 2005 | 262 | 0.010 |
Why?
| | Macrophage Activation | 1 | 1984 | 189 | 0.010 |
Why?
| | Mycobacterium tuberculosis | 1 | 1986 | 309 | 0.010 |
Why?
| | Dietary Fats | 1 | 1985 | 301 | 0.010 |
Why?
| | Mice, Inbred BALB C | 2 | 1996 | 1246 | 0.010 |
Why?
| | Blood Physiological Phenomena | 1 | 1982 | 13 | 0.010 |
Why?
| | Pulmonary Fibrosis | 1 | 1986 | 384 | 0.010 |
Why?
| | Cytological Techniques | 1 | 1982 | 26 | 0.010 |
Why?
| | Serum Albumin, Bovine | 1 | 1982 | 63 | 0.010 |
Why?
| | Feasibility Studies | 1 | 2005 | 865 | 0.010 |
Why?
| | Imidazoles | 1 | 1983 | 234 | 0.010 |
Why?
| | Stimulation, Chemical | 2 | 1978 | 63 | 0.010 |
Why?
| | Leukocyte Adherence Inhibition Test | 1 | 1981 | 1 | 0.010 |
Why?
| | Pulmonary Veins | 1 | 1982 | 98 | 0.010 |
Why?
| | Histoplasmosis | 1 | 1981 | 14 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 1983 | 405 | 0.010 |
Why?
| | Vacuoles | 2 | 1978 | 36 | 0.010 |
Why?
| | Bacterial Vaccines | 1 | 1981 | 62 | 0.010 |
Why?
| | Skin Tests | 1 | 1981 | 100 | 0.010 |
Why?
| | Enterococcus faecalis | 2 | 1979 | 26 | 0.010 |
Why?
| | Cytotoxicity, Immunologic | 1 | 1981 | 220 | 0.010 |
Why?
| | Ethane | 1 | 1979 | 2 | 0.010 |
Why?
| | Hexosephosphates | 1 | 1979 | 4 | 0.010 |
Why?
| | Anti-Inflammatory Agents | 1 | 1983 | 480 | 0.010 |
Why?
| | Keto Acids | 1 | 1979 | 13 | 0.010 |
Why?
| | Bacteriolysis | 1 | 1979 | 9 | 0.010 |
Why?
| | Ferrous Compounds | 1 | 1979 | 23 | 0.010 |
Why?
| | Peroxides | 1 | 1979 | 19 | 0.010 |
Why?
| | Chemistry | 1 | 1979 | 45 | 0.010 |
Why?
| | Depression, Chemical | 1 | 1979 | 22 | 0.010 |
Why?
| | Anesthesia, Local | 1 | 1979 | 16 | 0.010 |
Why?
| | Butyrates | 1 | 1979 | 57 | 0.010 |
Why?
| | Electromagnetic Phenomena | 1 | 1979 | 22 | 0.010 |
Why?
| | Aldehydes | 1 | 1979 | 142 | 0.010 |
Why?
| | Blastomyces | 1 | 1978 | 9 | 0.010 |
Why?
| | Immune Sera | 1 | 1978 | 87 | 0.010 |
Why?
| | Heterozygote | 1 | 1979 | 272 | 0.010 |
Why?
| | Immunoglobulins | 1 | 1978 | 160 | 0.010 |
Why?
| | Bronchoscopy | 1 | 1979 | 215 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 1982 | 1429 | 0.010 |
Why?
| | Species Specificity | 1 | 1978 | 574 | 0.010 |
Why?
| | Hypergammaglobulinemia | 1 | 1976 | 9 | 0.010 |
Why?
| | Phenylbutazone | 1 | 1976 | 2 | 0.010 |
Why?
| | Glycolysis | 1 | 1978 | 311 | 0.010 |
Why?
| | Leucine Zippers | 1 | 1996 | 17 | 0.010 |
Why?
| | Oligonucleotide Probes | 1 | 1996 | 50 | 0.010 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 1996 | 37 | 0.010 |
Why?
| | Eczema | 1 | 1976 | 67 | 0.010 |
Why?
| | Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 1995 | 5 | 0.010 |
Why?
| | Syndrome | 1 | 1976 | 339 | 0.010 |
Why?
| | Immunologic Deficiency Syndromes | 1 | 1975 | 64 | 0.010 |
Why?
| | Platelet Aggregation | 1 | 1975 | 95 | 0.010 |
Why?
| | Mitochondria, Liver | 1 | 1995 | 74 | 0.010 |
Why?
| | Protons | 1 | 1995 | 80 | 0.010 |
Why?
| | Genes, Dominant | 1 | 1975 | 92 | 0.010 |
Why?
| | Genes, Recessive | 1 | 1995 | 76 | 0.010 |
Why?
| | Fungal Proteins | 1 | 1995 | 130 | 0.010 |
Why?
| | Immunoglobulin E | 1 | 1976 | 329 | 0.010 |
Why?
| | Carbon Radioisotopes | 1 | 1974 | 33 | 0.010 |
Why?
| | Inclusion Bodies | 1 | 1974 | 23 | 0.010 |
Why?
| | Coloring Agents | 1 | 1974 | 77 | 0.010 |
Why?
| | Spleen | 1 | 1996 | 506 | 0.010 |
Why?
| | Staphylococcus | 1 | 1974 | 74 | 0.010 |
Why?
| | Rats, Inbred F344 | 1 | 1994 | 259 | 0.010 |
Why?
| | Vascular Diseases | 1 | 1975 | 240 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 1978 | 833 | 0.010 |
Why?
| | Ibuprofen | 1 | 1992 | 81 | 0.010 |
Why?
| | Solutions | 1 | 1991 | 150 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 1996 | 658 | 0.010 |
Why?
| | Blood | 1 | 1991 | 105 | 0.010 |
Why?
| | Staining and Labeling | 1 | 1991 | 141 | 0.010 |
Why?
| | Cold Temperature | 1 | 1991 | 154 | 0.010 |
Why?
| | Nitroglycerin | 1 | 1990 | 17 | 0.010 |
Why?
| | Insulin | 1 | 1980 | 2325 | 0.010 |
Why?
| | Half-Life | 1 | 1989 | 162 | 0.000 |
Why?
| | Child | 2 | 1979 | 20768 | 0.000 |
Why?
| | Blood Gas Analysis | 1 | 1989 | 71 | 0.000 |
Why?
| | DNA-Binding Proteins | 1 | 1996 | 1445 | 0.000 |
Why?
| | Microspheres | 1 | 1989 | 124 | 0.000 |
Why?
| | Complement C9 | 1 | 1988 | 5 | 0.000 |
Why?
| | Coronary Vessels | 1 | 1990 | 239 | 0.000 |
Why?
| | Fluoresceins | 1 | 1988 | 47 | 0.000 |
Why?
| | Fluorescein-5-isothiocyanate | 1 | 1988 | 37 | 0.000 |
Why?
| | Thiocyanates | 1 | 1988 | 31 | 0.000 |
Why?
| | Complement C5 | 1 | 1988 | 78 | 0.000 |
Why?
| | Quinidine | 1 | 1987 | 6 | 0.000 |
Why?
| | Procainamide | 1 | 1987 | 6 | 0.000 |
Why?
| | Phenotype | 1 | 1976 | 3071 | 0.000 |
Why?
| | Virulence | 1 | 1988 | 255 | 0.000 |
Why?
| | Heparin | 1 | 1988 | 253 | 0.000 |
Why?
| | Anti-Bacterial Agents | 1 | 1976 | 1702 | 0.000 |
Why?
| | Fluorescent Dyes | 1 | 1988 | 312 | 0.000 |
Why?
| | Swine | 1 | 1988 | 760 | 0.000 |
Why?
| | Aorta, Thoracic | 1 | 1988 | 262 | 0.000 |
Why?
| | Stroke Volume | 1 | 1988 | 592 | 0.000 |
Why?
| | Pleura | 1 | 1983 | 22 | 0.000 |
Why?
| | Micropore Filters | 1 | 1982 | 6 | 0.000 |
Why?
| | Cytochalasin B | 1 | 1982 | 17 | 0.000 |
Why?
| | Transducers, Pressure | 1 | 1982 | 13 | 0.000 |
Why?
| | Ultrafiltration | 1 | 1982 | 28 | 0.000 |
Why?
| | Polysaccharides, Bacterial | 1 | 1981 | 67 | 0.000 |
Why?
| | Tritium | 1 | 1980 | 75 | 0.000 |
Why?
| | Cytoplasmic Granules | 1 | 1979 | 78 | 0.000 |
Why?
| | Microvilli | 1 | 1978 | 79 | 0.000 |
Why?
| | Myristates | 1 | 1977 | 1 | 0.000 |
Why?
| | Histocompatibility Testing | 1 | 1975 | 120 | 0.000 |
Why?
|
|
Repine's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|